Many advanced and effective therapies have already undergone rigorous human testing in other parts of the world but are not known in North America. Our investigations will reveal these breakthroughs in best-in-class therapies that are improving lives in other parts of the world.
Revolution Through Research
Somata Biotech LLC, is revolutionizing medicine by researching advanced techniques in biological based therapies. Our focus is on revealing those therapies that are safe and effective as well as research and development into the best-in-class therapies available today.
Knowledge is Power
We stay current on the latest medical discovery breakthroughs, R&D developments in cellular medicine, and Preclinical Research with updates posted on this site. Check this site daily for frequent updates.
Somata Biotech is Leading the Field
Somata Biotech is collaborating with researchers from leading research institutions to investigate and promote safe and effective adult stem cell therapy through scientifically-based translational medicine.
Our database connects prospective patients with the most effective care and practice standards in emerging medical fields. Outcome based solutions are reported in ‘real time.’
Current Trending Videos
Phase One trials are now complete and selective stem cell placement (SSCP) has been confirmed as a potential breakthrough therapy for the treatment of Multiple Sclerosis. SSCP is a delivery technology with a demonstrated scienti?c and clinical proof of concept. This is the first time that a potential therapy has strongly demonstrated a return of function for patients. Linda Friesen is one of many study subjects who have had the SSCP therapy and as a result, have recovered function as their lives returned to ‘normalcy’, absent of symptoms and without the need for medications.Read more..
Somata Biotech, LLC has developed a novel platform for the treatment of Multiple Sclerosis (MS). Rather than ‘re-inventing the wheel’ through development of drugs, immunological factors (e.g. cytokines), or antibodies focused on symptomatic relief and functional improvement, Somata Biotech is attacking MS the most basic level; its root cause. Recent medical evidence indicates that MS begins as a brain blood vessel disorder, which leads to progressive neurological impairment. Using the patient’s stem cells, Somata Biotech has developed and tested a method of preparing and delivering these cells to areas of the brain where blood vessels, veins, are damaged and dysfunctional. The delivered stem cells correct the defect as evidenced by the long-term results of a multi-center phase 1 trial. Read more..